Birger Thorsteinsson Selected Research

Long-Acting Insulin (Insulin, Long Acting)

1/2022	Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open-label, crossover trial.
11/2021	Synthetic long-acting insulin analogs for the management of type 1 diabetes: an update.
7/2019	The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design.
6/2012	A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Birger Thorsteinsson Research Topics

Disease

40	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2023 - 03/2008
28	Hypoglycemia (Reactive Hypoglycemia) 09/2023 - 03/2005
10	Type 2 Diabetes Mellitus (MODY) 01/2022 - 02/2003
3	Weight Gain 02/2016 - 10/2006
2	Cognitive Dysfunction 01/2013 - 03/2008
1	Diabetes Complications 01/2022
1	Obstructive Sleep Apnea 01/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2020
1	Ischemia 02/2017
1	Coronary Occlusion 02/2017
1	Reperfusion Injury 02/2017
1	ST Elevation Myocardial Infarction 02/2017
1	Body Weight (Weight, Body) 12/2015
1	Gestational Weight Gain 12/2015
1	Diabetic Nephropathies (Diabetic Nephropathy) 06/2015
1	Myocardial Infarction 01/2015
1	Infarction (Infarctions) 01/2015
1	Pre-Eclampsia (Preeclampsia) 09/2011
1	Nausea 01/2008
1	Vomiting 01/2008

Drug/Important Bio-Agent (IBA)

27	Insulin (Novolin)FDA Link 01/2023 - 02/2003
20	Glucose (Dextrose)FDA LinkGeneric 09/2023 - 01/2008
10	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 10/2006
6	Insulin Glargine (Lantus)FDA Link 09/2023 - 07/2019
6	insulin degludecIBA 09/2023 - 07/2019
5	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 02/2016
5	Insulin Detemir (Levemir)FDA Link 11/2021 - 10/2006
5	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 06/2015 - 03/2008
4	Long-Acting Insulin (Insulin, Long Acting)FDA Link 01/2022 - 06/2012
3	Blood Glucose (Blood Sugar)IBA 01/2022 - 06/2015
3	Liraglutide FDA Link 02/2017 - 12/2015
2	Epinephrine (Adrenaline)FDA LinkGeneric 01/2023 - 05/2015
2	Biphasic InsulinsIBA 01/2022 - 02/2016
2	Isophane Insulin (NPH Insulin)FDA Link 11/2021 - 10/2006
2	Protamines (Protamine Sulfate)FDA Link 01/2018 - 10/2006
2	C-PeptideIBA 01/2018 - 07/2012
2	Hemoglobins (Hemoglobin)IBA 01/2018 - 11/2010
2	Glucagon (Glukagon)FDA Link 10/2017 - 11/2016
2	Insulin Aspart (NovoLog)FDA Link 10/2016 - 02/2016
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 12/2015 - 11/2009
2	Erythropoietin FDA Link 01/2013 - 07/2009
1	InsulinsIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	NAD (NADH)IBA 01/2020
1	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2017
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 02/2017
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2017
1	Growth Hormone (Somatotropin)IBA 12/2015
1	Insulin-Like Growth Factor I (IGF-1)IBA 12/2015
1	candesartanIBA 12/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2015
1	Angiotensin Receptor AntagonistsIBA 12/2015
1	Hydrocortisone (Cortisol)FDA LinkGeneric 05/2015
1	Troponin T (Troponin T1)IBA 01/2015
1	Hormones (Hormone)IBA 01/2013
1	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2011
1	Atrial Natriuretic Factor (ANF)IBA 09/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2009
1	AngiotensinogenIBA 03/2008
1	Psychotropic Drugs (Psychoactive Drugs)IBA 03/2005
1	Adenosine Triphosphate (ATP)IBA 02/2003

Therapy/Procedure

15	Therapeutics 01/2023 - 10/2006
5	Glycemic Control 01/2022 - 10/2006
2	Continuous Positive Airway Pressure 01/2021 - 01/2020
1	Ischemic Postconditioning 02/2017
1	Emergency Treatment 11/2009